Bitesize briefing – Shield Therapeutics

Bitesize briefing – Shield Therapeutics

Shield Therapeutics — 2 videos in collection

More on this equity

Shield Therapeutics is a UK-based, speciality pharmaceutical company with a primary focus on commercialising its drug Feraccru, which is approved in Europe for the treatment of iron deficiency, with or without anaemia. In this video , healthcare analyst Dr Sean Conroy provides an overview of Shield Therapeutics and outlines the company’s strategy for the commercialisation of Feraccru. He finishes the video by detailing Edison’s approach to valuing the company.

See latest research note here.

You may also be interested in these:


Executive interview - Shield Therapeutics

Subscribe to Edison

Get access to the very latest content matched to your personal investment style.

Sign up for free